NYSE:AGP - AMERIGROUP Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$5.25 0.00 (0.00 %)
(As of 06/21/2018 04:47 AM ET)
Previous Close$5.25
Today's Range$5.25 - $5.25
52-Week Range$56.41 - $91.97
VolumeN/A
Average VolumeN/A
Market Capitalization$4.70 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.08
AMERIGROUP logoAMERIGROUP Corporation is a multi-state managed healthcare company focused on serving people who receive healthcare benefits through publicly funded healthcare programs, including Medicaid, Children's Health Insurance Program (CHIP), Medicaid expansion programs and Medicare Advantage. The Company offers a continuum of care management, including disease management, pharmacy integration, centralized telephonic case management, in-person case management within healthcare facilities, and home visit case management for some of its members. As of December 31, 2011, the Company provided a number of healthcare products to approximately 2,024,000 members. Effective February 1, 2012, it provides managed care services in Louisiana. On May 1, 2012, it acquired Health Plus. In November 2012, the Company sold its Virginia health plan to Inova Health System Foundation. In December 2012, WellPoint Inc acquired the Company.

Receive AGP News and Ratings via Email

Sign-up to receive the latest news and ratings for AGP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNYSE:AGP
CUSIPN/A
Phone+1-757-4906900

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

AMERIGROUP (NYSE:AGP) Frequently Asked Questions

What is AMERIGROUP's stock symbol?

AMERIGROUP trades on the New York Stock Exchange (NYSE) under the ticker symbol "AGP."

Has AMERIGROUP been receiving favorable news coverage?

News articles about AGP stock have trended positive on Thursday, Accern Sentiment reports. The research group scores the sentiment of media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. AMERIGROUP earned a media sentiment score of 0.25 on Accern's scale. They also gave news stories about the healthcare company an impact score of 47.24 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near term.

How do I buy shares of AMERIGROUP?

Shares of AGP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is AMERIGROUP's stock price today?

One share of AGP stock can currently be purchased for approximately $5.25.

How big of a company is AMERIGROUP?

AMERIGROUP has a market capitalization of $4.70 billion.

How can I contact AMERIGROUP?

AMERIGROUP's mailing address is 4425 Corporation Ln Ste 100, VIRGINIA BEACH, VA 23462-3103, United States. The healthcare company can be reached via phone at +1-757-4906900.


MarketBeat Community Rating for AMERIGROUP (AGP)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  152 (Vote Outperform)
Underperform Votes:  185 (Vote Underperform)
Total Votes:  337
MarketBeat's community ratings are surveys of what our community members think about AMERIGROUP and other stocks. Vote "Outperform" if you believe AGP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AGP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.